Targeted therapy in pediatric and adolescent oncology

In Vivo Antitumor and Antimetastatic Activity of Sunitinib in Preclinical Neuroblastoma Mouse Model

(2015) Libo Zhang et al.   NEOPLASIA

Lestaurtinib Enhances the Antitumor Efficacy of Chemotherapy in Murine Xenograft Models of Neuroblastoma

(2010) R. Iyer et al.   CLINICAL CANCER RESEARCH

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Advances in the biology and therapy of patients with chronic myeloid leukaemia

(2009) Elias Jabbour et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML

(2009) K. W. Pratz et al.   BLOOD

Angiogenesis and vascular targeting in Ewing sarcoma

(2009) Steven G. DuBois et al.   CANCER

Response to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma

(2009) S. Stacchiotti et al.   CLINICAL CANCER RESEARCH

On Trk--The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology

(2009) C. J. Thiele et al.   CLINICAL CANCER RESEARCH

Preclinical evaluation of vascular-disrupting agents in Ewing’s sarcoma family of tumours

(2009) Surita Dalal et al.   EUROPEAN JOURNAL OF CANCER

Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms

(2009) Hrvoje Miletic et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

(2009) Kirk R. Schultz et al.   JOURNAL OF CLINICAL ONCOLOGY

Innovative approaches of targeted therapy for CML of childhood in combination with paediatric haematopoietic SCT

(2008) M Suttorp   BONE MARROW TRANSPLANTATION

Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults

(2008) Divya Menon-Andersen et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study

(2008) Julia L. Glade Bender et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem-Cell Rescue: A Report From the Children's Oncology Group

(2008) Andrew L. Gilman et al.   JOURNAL OF CLINICAL ONCOLOGY